Sermorelin dosage for weight loss is usually 100–300 mcg at bedtime, but no dose is FDA-approved for fat loss. Here's what the evidence actually shows.
The most commonly cited sermorelin dosage for weight loss is 100 to 300 mcg injected subcutaneously once daily at bedtime, often five days on and two days off. However, sermorelin is not FDA-approved for weight loss, and no dose has been proven in clinical trials to produce meaningful fat loss on its own. Clinics that offer it typically combine it with calorie control, resistance training, and sometimes prescription GLP-1 medications.
What Is a Typical Sermorelin Dose for Weight Loss?
Sermorelin is a synthetic form of growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release growth hormone, which is why it gets discussed alongside body composition goals. Dosing in wellness clinics is not standardized, so the ranges vary widely.
| Protocol | Typical dose | Frequency | Notes |
|---|---|---|---|
| Standard clinic protocol | 100–300 mcg | Once nightly | Most common; often 5 days on, 2 days off |
| Low-dose starter | 100 mcg | Once nightly | Used for the first week or two to check tolerance |
| Higher-dose protocol | 300–500 mcg | Once nightly | Less common; more reports of flushing, headache, and injection-site reactions |
| Historical prescription label | 0.2 mcg/kg | Once nightly | Geref, approved for pediatric growth hormone deficiency — never for weight loss |
Notice what is missing from that table: a dose shown in controlled trials to cause weight loss. Sermorelin acetate is the only version ever approved by the FDA, and research on sermorelin-acetate for weight loss is limited and largely indirect.
Does Sermorelin Actually Cause Weight Loss?
The honest answer is that the evidence is weak. Sermorelin raises growth hormone and IGF-1, and growth hormone does influence fat metabolism and lean muscle. But raising those markers is not the same thing as losing pounds.
- Most published sermorelin data comes from growth hormone deficiency research in children, not obesity trials in adults.
- Existing studies are small, short, and rarely measure body weight as a primary outcome.
- Fat loss reported in clinic settings is usually confounded by diet, exercise, and other medications used at the same time.
- Growth hormone itself is not an approved obesity treatment, and off-label use for weight loss remains controversial.
Some users report better sleep, faster recovery, and slightly easier fat loss. Those are anecdotes, not proof. Sermorelin is not a substitute for a calorie deficit, and it does not compare to drugs backed by large randomized trials.
Sermorelin vs. Other Peptides and Weight Loss Medications
If fat loss is the real goal, it helps to see sermorelin next to the alternatives. Comparing tirzepatide vs semaglutide dosage for weight loss is a far more relevant exercise than fine-tuning a sermorelin protocol, because those drugs have phase 3 data and FDA approval for chronic weight management.
| Compound | What it is | Typical research or clinical dose | Evidence for weight loss |
|---|---|---|---|
| Sermorelin | GHRH analog | 100–300 mcg nightly | Weak and indirect |
| CJC-1295 DAC | Long-acting GHRH analog | 1–2 mg weekly | Weak; no obesity outcomes published |
| Ipamorelin | Ghrelin receptor agonist | 200–300 mcg, 1–3x daily | Weak |
| Tirzepatide | Dual GIP/GLP-1 agonist | 2.5 mg weekly, titrated to 5–15 mg | Strong; FDA-approved for weight management |
| Semaglutide | GLP-1 agonist | 0.25 mg weekly, titrated to 1.7–2.4 mg | Strong; FDA-approved for weight management |
A tirzepatide dosage chart for weight loss typically starts at 2.5 mg once weekly for four weeks, then steps up to 5 mg, with further increases at four-week intervals as tolerated. That structured titration is a big reason those medications outperform anything measured in a sermorelin cycle.
Where the other peptides fit
Growth hormone secretagogues are often stacked together outside medical settings. Discussions about cjc-1295 dac dosage for weight loss usually settle on roughly 1 to 2 mg per week, and people searching for mots-c dosage for weight loss are looking at a mitochondrial-derived peptide with almost no human safety data. Neither has been shown to produce clinically significant weight loss.
How Sermorelin Is Used: Timing and Practical Details
- Timing: Inject at night, ideally 30 to 60 minutes before sleep, since most natural growth hormone release happens during deep sleep.
- Empty stomach: Avoid food for about two hours before and 30 minutes after the injection, because insulin and glucose blunt GH release.
- Injection site: Subcutaneous in the abdomen, thigh, or upper arm; rotate sites to prevent lipohypertrophy.
- Cycle length: Clinics often recommend 3 to 6 months before judging results, with periodic IGF-1 lab checks.
- Storage: Keep reconstituted vials refrigerated and protect the powder from light.
Consistency matters more than chasing a higher number. Increasing the dose does not proportionally increase growth hormone release, and it does raise the odds of side effects.
Side Effects and Safety
Reported side effects include injection-site redness, flushing, headache, dizziness, and sometimes increased appetite or joint aches. Because sermorelin raises IGF-1, long-term use carries theoretical concerns about insulin resistance and cell proliferation, which is why lab monitoring matters.
Sermorelin should be used only under medical supervision with baseline and follow-up labs, not sourced from unregulated online vendors.
People who are pregnant, have active cancer, or have uncontrolled diabetes should not use sermorelin. It is also banned by the World Anti-Doping Agency, so athletes subject to drug testing should avoid it.
Legal Status and Buying Considerations
Sermorelin requires a prescription in the United States, and it is not approved for weight loss at any dose. Many products sold as "research grade" peptides are unregulated, may be mislabeled, and may contain no active ingredient at all. If a vendor promises fat loss from sermorelin alone, treat that claim with skepticism.
Before starting anything, talk with a licensed healthcare provider about your goals, your labs, and whether a medication with real weight loss data is a better fit.
Frequently Asked Questions
What is the best sermorelin dosage for weight loss?
There is no established best dose, because sermorelin has not been proven to cause weight loss in clinical trials. Most clinics use 100 to 300 mcg injected subcutaneously at bedtime. Going above that range raises side effect risk without clear added benefit.
How long does sermorelin take to work for weight loss?
Clinics typically suggest 8 to 12 weeks before evaluating any effect, and 3 to 6 months for a full cycle. Even then, changes are usually modest and tied to diet and training rather than the peptide itself. Sermorelin is not a rapid fat-loss drug.
Is sermorelin better than semaglutide or tirzepatide for losing weight?
No. Semaglutide and tirzepatide are FDA-approved for chronic weight management and have large randomized trials showing substantial weight loss. Sermorelin has no comparable data and is not approved for weight loss at any dose. It may support sleep and recovery, but it is not a replacement for proven treatments.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.